SE437028B - Forfarande for framstellning av d,l-5-metyltetrahydro-folsyra - Google Patents

Forfarande for framstellning av d,l-5-metyltetrahydro-folsyra

Info

Publication number
SE437028B
SE437028B SE7801973A SE7801973A SE437028B SE 437028 B SE437028 B SE 437028B SE 7801973 A SE7801973 A SE 7801973A SE 7801973 A SE7801973 A SE 7801973A SE 437028 B SE437028 B SE 437028B
Authority
SE
Sweden
Prior art keywords
acid
ratio
process according
carried out
folic acid
Prior art date
Application number
SE7801973A
Other languages
English (en)
Swedish (sv)
Other versions
SE7801973L (sv
Inventor
F Gennari
Original Assignee
Bioresearch Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Sas filed Critical Bioresearch Sas
Publication of SE7801973L publication Critical patent/SE7801973L/xx
Publication of SE437028B publication Critical patent/SE437028B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE7801973A 1977-02-22 1978-02-21 Forfarande for framstellning av d,l-5-metyltetrahydro-folsyra SE437028B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7290/77A GB1572137A (en) 1977-02-22 1977-02-22 Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts

Publications (2)

Publication Number Publication Date
SE7801973L SE7801973L (sv) 1978-08-23
SE437028B true SE437028B (sv) 1985-02-04

Family

ID=9830275

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801973A SE437028B (sv) 1977-02-22 1978-02-21 Forfarande for framstellning av d,l-5-metyltetrahydro-folsyra

Country Status (32)

Country Link
JP (1) JPS5831353B2 (es)
AR (1) AR215162A1 (es)
AT (1) AT380020B (es)
AU (1) AU520715B2 (es)
BE (1) BE863808A (es)
CA (1) CA1093554A (es)
CH (1) CH635344A5 (es)
CZ (1) CZ279815B6 (es)
DD (1) DD134099A5 (es)
DE (1) DE2807393A1 (es)
DK (1) DK144944C (es)
EG (1) EG13399A (es)
ES (1) ES467153A1 (es)
FI (1) FI67082C (es)
FR (2) FR2381047A1 (es)
GB (1) GB1572137A (es)
GR (1) GR71704B (es)
HU (1) HU179422B (es)
IE (1) IE46402B1 (es)
IL (1) IL54052A (es)
IN (1) IN149574B (es)
LU (1) LU79067A1 (es)
MX (1) MX5288E (es)
NL (1) NL190285C (es)
NO (1) NO147793C (es)
NZ (1) NZ186465A (es)
PL (1) PL118654B1 (es)
PT (1) PT67656B (es)
SE (1) SE437028B (es)
SU (1) SU747427A3 (es)
YU (1) YU40505B (es)
ZA (1) ZA78837B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5838285A (ja) * 1981-08-25 1983-03-05 Kanegafuchi Chem Ind Co Ltd 5−メチル−(6rs)−5,6,7,8−テトラヒドロ−l−葉酸のマグネシウム塩またはその遊離酸の製法
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
NL8901432A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
CH680731A5 (es) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
CH683261A5 (it) * 1991-10-10 1994-02-15 Applied Pharma Res Procedimento per la preparazione dell'acido metiltetraidrofolico nella forma (6(R,S)(-))N-5 e separazione del diastereoisomero attivo (6(S)(-))N-5) sotto forma di sali.
CH682665A5 (de) * 1991-10-29 1993-10-29 Sapec Fine Chemicals Verfahren zur Reinigung von rohen Erdalkalimetallsalzen von N(5)-Methyl-5,6,7,8-tetrahydrofolsäure.
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN103214487A (zh) * 2013-04-12 2013-07-24 张家港威胜生物医药有限公司 一种重要医药化工原料(6s)-5-甲基四氢叶酸盐的合成
WO2015193778A1 (en) 2014-06-16 2015-12-23 Mylan Laboratories Ltd. Crystalline form of levomefolate calcium
MX2021002446A (es) 2018-08-28 2021-04-28 Pmc Organometallix Inc Ester libre o con bajo contenido de 2-mercaptoetanol y usos del mismo.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL80276C (es) *
GB1293541A (en) * 1969-03-18 1972-10-18 John Alexander Blair Folic acid derivatives
US3856959A (en) * 1972-07-24 1974-12-24 Department Of Health Education Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor
CH649550A5 (en) * 1984-02-09 1985-05-31 Eprova Ag Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid

Also Published As

Publication number Publication date
NO147793B (no) 1983-03-07
FI67082B (fi) 1984-09-28
PL118654B1 (en) 1981-10-31
CZ112978A3 (en) 1995-02-15
NO780594L (no) 1978-08-23
FR2381047A1 (fr) 1978-09-15
JPS53124297A (en) 1978-10-30
SU747427A3 (ru) 1980-07-23
SE7801973L (sv) 1978-08-23
ATA90378A (de) 1985-08-15
MX5288E (es) 1983-06-06
CA1093554A (en) 1981-01-13
NL7801775A (nl) 1978-08-24
DD134099A5 (de) 1979-02-07
IE46402B1 (en) 1983-06-01
GB1572137A (en) 1980-07-23
IE780285L (en) 1978-08-22
CZ279815B6 (cs) 1995-07-12
FI67082C (fi) 1985-01-10
EG13399A (en) 1981-12-31
DK144944B (da) 1982-07-12
AU520715B2 (en) 1982-02-25
ZA78837B (en) 1979-09-26
IL54052A (en) 1981-07-31
PT67656A (en) 1978-03-01
FI780565A (fi) 1978-08-23
DK144944C (da) 1982-11-29
DE2807393A1 (de) 1978-09-07
NL190285C (nl) 1994-01-03
LU79067A1 (fr) 1978-06-27
CH635344A5 (en) 1983-03-31
YU37978A (en) 1983-01-21
IL54052A0 (en) 1978-04-30
FR2385397A1 (fr) 1978-10-27
NO147793C (no) 1983-06-15
IN149574B (es) 1982-01-30
AR215162A1 (es) 1979-09-14
HU179422B (en) 1982-10-28
BE863808A (fr) 1978-05-29
PT67656B (en) 1979-07-19
NL190285B (nl) 1993-08-02
AT380020B (de) 1986-03-25
YU40505B (en) 1986-02-28
GR71704B (es) 1983-06-21
PL204747A1 (pl) 1979-03-12
DK76578A (da) 1978-08-23
FR2385397B1 (es) 1981-07-17
AU3343078A (en) 1979-08-30
NZ186465A (en) 1980-10-08
JPS5831353B2 (ja) 1983-07-05
FR2381047B1 (es) 1981-07-24
DE2807393C2 (es) 1990-06-13
ES467153A1 (es) 1978-11-16

Similar Documents

Publication Publication Date Title
SE437028B (sv) Forfarande for framstellning av d,l-5-metyltetrahydro-folsyra
US5124452A (en) Process for producing d,1-5-methyltetrahydrofolic acid and its salts
Simmons et al. Thiacyanocarbons. I. Tetracyano-1, 4-dithiin, Tetracyanothiophene and Tricyano-1, 4-dithiino [c] isothiazole
JPH02167286A (ja) クラバラン酸の塩、その製法及び用途
JPH07506192A (ja) タンパク質構造決定のための組成物類および方法類
IE911224A1 (en) Ammonium salts of n5-methyl-5,6,7,8-tetrahydrofolic acid
KR20050044506A (ko) 결정질 이미페넴의 제조 방법
CN105566445B (zh) 一种分离纯化还原型谷胱甘肽的方法
US5223500A (en) Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate
DK151340B (da) Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat
US2760956A (en) Production of s-acetyl glutathione
JPS5824569A (ja) イミダゾ−ル誘導体の精製方法
JPH0267284A (ja) ピロロキノリンキノン類の回収・精製方法
JPS62246575A (ja) ピロロキノリンキノンの精製方法
Kaminski et al. 3-Bromo-4, 4-dimethyl-2-oxazolidinone: Preparation and investigation of a new brominating agent
JPH05500375A (ja) 9―ベータ―d―アラビノフラノシル―2―フルオロアデニン 5’―ホスフェートの製造法
GB1561954A (en) Monolithium salt of -nicotinamideadenine-dinucleotide
IE45801B1 (en) Crystalline potassium salt of -nicotinamide-adenine-dinucleotide-phosphoric acid
CS235331B2 (en) Method of cephoperazone's crystalline salt production
JPH0812693A (ja) アスコルビン酸誘導体の製造法
FI73976C (fi) Foerfarande foer foerdelning av racematet s-(karboximetyl)-(r,s)-cystein i isomerer.
GB1572138A (en) Process for the preparation of d,1-5-methyltetrahydrofolic acid
JPH02131494A (ja) 結晶状l−アスコルビン酸−2−リン酸ナトリウム塩の製造法
CN110669061A (zh) 一种头孢地尼二聚物杂质的制备方法
JPH0383593A (ja) オキセタノシンgの製造法

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7801973-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7801973-4

Format of ref document f/p: F